228,714 Shares in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Acquired by Altium Capital Management LP

Altium Capital Management LP acquired a new stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 228,714 shares of the biopharmaceutical company’s stock, valued at approximately $1,578,000. Altium Capital Management LP owned about 0.45% of Marinus […]

Related Keywords

Scott Braunstein ,Steven Pfanstiel ,Marinus Pharmaceuticals ,Denali Advisors ,News Ratings For Marinus Pharmaceuticals Daily ,Quarter For Marinus Pharmaceuticals ,Marinus Pharmaceuticals Trading ,Marinus Pharmaceuticals Inc ,Nasdaq ,Securities Exchange Commission ,Marinus Pharmaceuticals Company Profile ,Altium Capital Management ,Free Report ,Capital Management ,Street Group ,Get Free Report ,Exchange Commission ,Marinus Pharmaceuticals Daily ,Nasdaq Mrns ,Mrns ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,